Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon.
"Ozempic Face" May Not Be Worth The Weight Loss. #ozempic #weightloss #health Weight Loss Drops Near Me
Location
Lisbon
Publication date
Reference
News release
In United States Publish Post Time: 2025-07-29
If you've heard the buzz about Ozempic and thinking about taking it for weight loss you may want to reconsider.
The popularity of Ozempic, a semaglutide drug for regulating insulin, suppressing appetite, and lowering the risk of cardiovascular events for diabetic patients, has led to shortages and a rise in trend stories about heroin-chic thinness.
Despite its slimming side effects, use of the drug has also led to a rise in what some doctors are calling "Ozempic face," sagging and wrinkles caused by rapid weight loss.
Dermatologists report an increase in treatment requests for facial wrinkles and hair loss, and some have expressed concern over serious side effects including vision changes and organ inflammation.
"Ozempic Face" May Not Be Worth The Weight Loss. #ozempic #weightloss #health For Country: United States. City: Jacksonville, Omaha, Scottsdale, Syracuse, Temecula
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:
Kathy Robertson
Principal manager
Media relations and corporate communication